The role of CDK6 in MPNs is currently unclear: mice with Cdk6 deletion along with JAK2 V617F exhibited a somewhat less severe MPN phenotype than mice with JAK2 V617F alone, but observed effects on NFκB target gene expression were ambiguous (117). This evidence concerns the gene CDK6 and myeloproliferative neoplasm.